chinese glp-1 Innovent's weight-loss drug highlights China challenge for Novo, Lilly How to Spend the Chinese

This review addresses the role of semaglutide (SMG), a GLP-1 receptor agonist, in the treatment of obesity and its related comorbidities

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

Each bottle offers 3 months of supply

p 40 are at substantially increased risk of major depression and anxiety disorders

Adults with obesity and autoimmune disease taking GLP-1 medication experience fewer cardiac events and have a lower risk of death, according to new findings.

A recently published study found that social judgments extend beyond whether you lose weight or not, but also to how you do it.